StockData
Kamada Ltd logo

Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30
$8.07−0.09 (-1.10%)

Close on Nov 18, 2026Market cap $465.53MP/E –Yield –

Kamada revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Kamada's revenue for the twelve months ending Jun 30, 2026 was $191.85M, up 13.2% year over year. For fiscal 2025 it was $180.46M, up 12.1% from the year before. Over ten years it grew 9.9% a year on average. The highest annual figure on record is $180.46M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$180.46M+12.1%
FY2024Dec 31, 2024$160.95M+12.9%
FY2023Dec 31, 2023$142.52M+10.2%
FY2022Dec 31, 2022$129.34M+24.8%
FY2021Dec 31, 2021$103.64M-22.2%
FY2020Dec 31, 2020$133.25M+4.8%
FY2019Dec 31, 2019$127.19M+11.1%
FY2018Dec 31, 2018$114.47M+11.3%
FY2017Dec 31, 2017$102.83M+32.7%
FY2016Dec 31, 2016$77.49M+10.9%
FY2015Dec 31, 2015$69.91M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$54.92M+22.7%
Q1 FY2026Mar 31, 2026$45.24M+2.8%
Q4 FY2025Dec 31, 2025$44.68M+14.5%
Q3 FY2025Sep 30, 2025$47.01M+12.6%
Q2 FY2025Jun 30, 2025$44.75M+5.4%
Q1 FY2025Mar 31, 2025$44.02M+16.6%
Q4 FY2024Dec 31, 2024$39.01M+7.1%
Q3 FY2024Sep 30, 2024$41.74M+10.0%
Q2 FY2024Jun 30, 2024$42.47M+13.4%
Q1 FY2024Mar 31, 2024$37.74M+122778.5%
Q4 FY2023Dec 31, 2023$36.43M-71.8%
Q3 FY2023Sep 30, 2023$37.93M+117645.3%
Q2 FY2023Jun 30, 2023$37.44M+58.7%
Q1 FY2023Mar 31, 2023$30.71K-99.9%
Q4 FY2022Dec 31, 2022$129.26M+310.7%
Q3 FY2022Sep 30, 2022$32.22K-99.9%
Q2 FY2022Jun 30, 2022$23.59M-2.7%
Q1 FY2022Mar 31, 2022$28.09M-10.9%
Q4 FY2021Dec 31, 2021$31.47M-10.9%
Q3 FY2021Sep 30, 2021$23.03M–
Q2 FY2021Jun 30, 2021$24.24M–
Q4 FY2020Dec 31, 2020$31.54M–
Q3 FY2020Sep 30, 2020$35.33M–

More Kamada figures

See a number that looks wrong?